ArticleBMC ophthalmology2026
Bilateral steroid-induced glaucoma following monocular steroid therapy: a case report.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundFollowing keratoplasty, the use of steroids is typically necessary to control postoperative inflammation and prevent graft rejection. However, improper management can lead to elevated intraocular pressure (IOP) and glaucoma. In our view, the use of topical steroid eye drops in one eye is unlikely to cause bilateral steroid-induced glaucoma. CASE PRESENTATION: An 18-year-old male with a history of keratoconus in both eyes and deep anterior lamellar keratoplasty (DALK) in the right eye. Postoperatively, the patient was prescribed 0.1% fluorometholone three times daily in the right eye, and elevated IOP was detected in both eyes. After three months of treatment, glaucomatous damage advanced, and anterior segment examination revealed posterior subcapsular cataract in both eyes. IOP remained uncontrolled and a diagnosis of bilateral steroid-induced glaucoma was established.
conclusionMonocular administration of topical steroids may be associated with bilateral steroid-induced glaucoma in susceptible individuals. We need to emphasize the importance of close monitoring and early intervention for patients taking steroid eye drops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.